Serum cytidine deaminase levels after withdrawal of non-steroidal anti-inflammatory treatment in rheumatoid arthritis.
Open Access
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 47 (4) , 308-312
- https://doi.org/10.1136/ard.47.4.308
Abstract
Increases in joint inflammation in nine patients with rheumatoid arthritis were provoked by withdrawal of their non-steroidal anti-inflammatory drugs. Pain score, duration of morning stiffness, Ritchie articular index score, and the number of analgesic tablets consumed reached peaks after five, three, five, and five days respectively compared with values during six days of normal treatment. Changes in serum cytidine deaminase (believed to reflect polymorph turnover in inflamed joints) showed a different pattern, with a sharp peak after two days and a subsequent trough. Possible mechanisms for these differences are discussed.This publication has 12 references indexed in Scilit:
- LABORATORY MARKERS OF JOINT INFLAMMATION AND DAMAGERheumatology, 1987
- Reduced in vivo leucocyte migration and elastase and lysozyme concentrations in skin chamber experiments with piroxicam in healthy volunteers.1986
- Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1986
- Inhibition of in vivo leucocyte migration by NSAIDs.1985
- Rheumatoid arthritis--anti-inflammatory drugs.1983
- Activity of serum cytidine deaminase during pregnancyBJOG: An International Journal of Obstetrics and Gynaecology, 1982
- Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.1968
- Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.BMJ, 1967
- GRANULOCYTE SURVIVAL IN SYNOVIAL EXUDATE OF PATIENTS WITH RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY JOINT DISEASES1967
- A SIMPLE DIRECT AND SENSITIVE TECHNIQUE FOR MEASUREMENT OF SPECIFIC PROTEIN IN DILUTE SOLUTION1967